| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.08 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.09 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.09 |